Itch FX
Natural health product licensed in Canada
- Licence holder
- JRC Pharmaceuticals
- NPN or DIN-HM
- 80085832
- Status
- Active licence
- Licence date
- 4 June 2018
- Revision date
- Not provided
- Form
- Solution
- Route of administration
- Topique
- Application type
- Officinale
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| (11bêta)-11,17,21-trihydroxy-prégn-4-ène-3,20-dione Source : Hydrocortisone | 0.5 Pour cent |
Non-medicinal ingredients
Propylène glycol, Eau
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes et enfants | minimum: 2 years | Not specified | Not specified |
Uses authorised in Canada
For temporary relief of minor skin irritations, rashes, itching and redness due to eczema, insect bites, poison ivy, poison oak, poison sumac, contact dermatitis, seborrheic dermatitis, psoriasis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
For external use only If symptoms worsen or persist more than 7 days, or clear up and occur again within a few days, stop use of this product and do not begin use of any other hydrocortisone product unless directed by a health care practitioner.
- Contre-indications
Do not use in or around the eyes. Do not apply to large areas. Do not use on children 2 years of age or younger, except on the advice of a health care practitioner. Do not use for the treatment of diaper rash, except on the advice of a health care practitioner.
Source
Official Health Canada record, licence 80085832
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.